We demonstrated that EGFR wt with SRGN over-expression patients was displayed as inflamed tumors, but associated with “cancer-promoting inflammation”, which shaped TME toward a tumor-permissive state by chronic inflammation and immune evasion [53]. This evidence concerns the gene EGFR and cancer.